New Key Statistics Module, Z-Score and F-Score
NAS:ICCC Key Ratios
| Market Cap $ M | 27.65 |
| Enterprise Value $ M | 42.16 |
| P/E(ttm) | -- |
| PE Ratio without NRI | -- |
| Forward PE Ratio | -- |
| Price/Book | 1.18 |
| Price/Sales | 1.18 |
| Price/Free Cash Flow | -- |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 23.00 |
| EPS (TTM) $ | -0.53 |
| Beneish M-Score | -2.72 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | -12.20 |
| EV-to-EBITDA | -56.82 |
| PEG | -- |
| Shares Outstanding M | 7.83 |
| Net Margin (%) | -17.44 |
| Operating Margin % | -16.68 |
| Pre-tax Margin (%) | -17.42 |
| Quick Ratio | 0.77 |
| Current Ratio | 2.37 |
| ROA % (ttm) | -9.32 |
| ROE % (ttm) | -16.08 |
| ROIC % (ttm) | -9.70 |
| Dividend Yield % | -- |
| Altman Z-Score | 0.90 |
ICCC Number of Guru Trades
ICCC Volume of Guru Trades
Gurus Latest Trades with NAS:ICCC
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:ICCC is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
ImmuCell Corp Insider Transactions
No Available Data
News about NAS:ICCC
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers